Troluce Capital Advisors’s Qiagen QGEN Stock Holding History

Troluce Capital Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-362,500	Closed	-$14.5M	–	74
2026 Q1	$14.5M	Buy	+362,500	New	+$17.2M	0.89%	39

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Troluce Capital Advisors's QGEN Position: Q2 2026 in Review

Troluce Capital Advisors sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 362,500 shares — an estimated $14.5M sold.

Troluce Capital Advisors first reported a position in QGEN in Q1 2026 and held it in 1 quarter. The position peaked at $14.5M in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Troluce Capital Advisors reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Troluce Capital Advisors sold 362,500 Qiagen shares in Q2 2026, an estimated $14.5M.
Troluce Capital Advisors first reported a position in Qiagen in Q1 2026 and held it in 1 quarter.
Troluce Capital Advisors's Qiagen position peaked at $14.5M in Q1 2026.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Troluce Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.